Organovo (ONVO) Projected to Post Earnings on Thursday

Organovo (NASDAQ:ONVO) is expected to announce its earnings results before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of ($0.21) per share and revenue of $0.05 million for the quarter.

Organovo (NASDAQ:ONVO) last posted its quarterly earnings results on Friday, November 8th. The medical research company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.12. Organovo had a negative return on equity of 249.28% and a negative net margin of 12,176.70%. The business had revenue of $0.03 million for the quarter, compared to the consensus estimate of $0.04 million. On average, analysts expect Organovo to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Organovo Stock Up 1.4 %

Shares of NASDAQ:ONVO opened at $0.34 on Thursday. Organovo has a twelve month low of $0.32 and a twelve month high of $1.74. The stock’s 50 day moving average is $0.40 and its 200-day moving average is $0.46. The firm has a market capitalization of $5.28 million, a price-to-earnings ratio of -0.32 and a beta of 0.54.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on shares of Organovo in a report on Thursday, January 30th. They set a “sell” rating on the stock.

Organovo Company Profile

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.